[Analysis of the resistance gene in Streptococcus pneumoniae]

Hitoshi Miyamoto1, Mitsuharu Murase

  • 1Department of Clinical Laboratory, Ehime University Hospital.

Insights

Streptococcus pneumoniae strains show increasing resistance to antibiotics like penicillin and macrolides due to gene mutations. This rise in antimicrobial resistance, particularly in fluoroquinolone-resistant strains, signals future treatment challenges.

Area of Science:

  • Microbiology
  • Genetics
  • Infectious Diseases

Context:

  • Investigated antimicrobial resistance in *Streptococcus pneumoniae*.
  • Analyzed 81 clinical isolates from Ehime University Hospital (2002-2003).
  • Focused on resistance mechanisms in penicillin-binding proteins (PBPs), macrolide resistance genes, and fluoroquinolone resistance genes.

Purpose:

  • Determine the prevalence of specific resistance genes in *Streptococcus pneumoniae*.
  • Identify mutations in penicillin-binding protein (PBP) genes (pbp2x, pbp2b, pbp1a).
  • Characterize macrolide resistance genes (mefA, ermB) and fluoroquinolone resistance genes (gyrA, parC).

Summary:

  • High rates of PBP mutations were observed, with combined mutations in pbp2x and pbp2b being common.
  • The *ermB* gene was the predominant macrolide resistance gene, found in 56.8% of isolates.
  • Fluoroquinolone resistance was associated with *gyrA* and *parC* gene mutations, with *parC* mutations being more frequent.

Impact:

  • Observed a concerning increase in multi-drug resistant strains, including those with PBP and *ermB* gene mutations.
  • Found a high co-occurrence of *gyrA*/*parC* mutations with PBP and macrolide resistance genes.
  • Suggests a growing trend of antimicrobial resistance in *Streptococcus pneumoniae*, necessitating further surveillance and treatment strategy development.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...